Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos.
As Angie explains, the industry still lacks the transparency needed to effectively manage where discounts occur and how funds move across stakeholders. She argues that improving visibility and coordination across the ecosystem is essential to building a more sustainable and accountable model for both innovation and patient support.
US Pharma Marketing
